We are live on ! Find out more
HAE icon

Haemonetics
HAE

270 hedge funds and large institutions have $3.83B invested in Haemonetics in 2022 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 84 increasing their positions, 101 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

152% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 21

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

13% more capital invested

Capital invested by funds: $3.39B → $3.83B (+$439M)

12% more funds holding

Funds holding: 241 → 270 (+29)

0.5% less ownership

Funds ownership: 101.35% → 100.85% (-0.5%)

9% less call options, than puts

Call options by funds: $4.6M | Put options by funds: $5.08M

17% less repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 101

Holders
270
Holders Change
+29
Holders Change %
+12.03%
% of All Funds
4.65%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
53
Increased
84
Reduced
101
Closed
21
Calls
$4.6M
Puts
$5.08M
Net Calls
-$482K
Net Calls Change
+$1.7M

Top Buyers

1
Millennium Management
Millennium Management
New York
+$29M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$17.3M
3
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$15.7M
4
Neuberger Berman Group
Neuberger Berman Group
New York
+$12.5M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$12.4M

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
-$45.3M
2
RRAM
River Road Asset Management
Kentucky
-$26.9M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$21.8M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$19.5M
5
LCP
LGT Capital Partners
Switzerland
-$15.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Walleye Trading
276
Walleye Trading
New York
– -$722K -11,084 Closed
GF
277
Gabelli Funds
New York
– -$424K -6,500 Closed
PP
278
PDT Partners
New York
– -$372K -5,703 Closed
PHK
279
Point72 Hong Kong
Hong Kong
– -$225K -3,445 Closed
CCIA
280
Campbell & Co Investment Adviser
Maryland
– -$212K -3,247 Closed
CAPTRUST Financial Advisors
281
CAPTRUST Financial Advisors
North Carolina
– -$147K -2,250 Closed
FIA
282
FNY Investment Advisers
New York
– -$75K -1,156 Closed
SWM
283
SeaCrest Wealth Management
New York
– -$65K -1,000 Closed
TF
284
Tompkins Financial
New York
– -$37K -560 Closed
Rockefeller Capital Management
285
Rockefeller Capital Management
New York
– -$25K -386 Closed
EC
286
Elequin Capital
New York
– -$3K -53 Closed
RF
287
Robbins Farley
New Hampshire
– -$3K -50 Closed
STCOSD
288
Sageworth Trust Company of South Dakota
South Dakota
– -$3K -42 Closed
SFG
289
Steward Financial Group
Texas
– -$1K -20 Closed
C
290
Covestor
United Kingdom
– -$144 -2 -33%
FMP
291
Financial Management Professionals
Texas
– +$215 +3 New
8 9 10 11
12

HAE Hedge Fund Activity: Q3 2022 in Review

270 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q3 2022, worth a combined $3.83B — up 13% from $3.39B a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new HAE positions and 21 closed out — a net gain of 32 holders — while 84 added to existing stakes and 101 trimmed.

The largest buyer was Millennium Management, adding an estimated $29M. The largest seller was Citadel Advisors, cutting an estimated $45.3M.

  • 270 institutional investors held Haemonetics (HAE) as of Q3 2022, up from 241 in Q2 2022.
  • Funds reported $3.83B of Haemonetics stock for Q3 2022, up 13% quarter-over-quarter.
  • 53 funds opened new Haemonetics positions in Q3 2022 and 21 closed out, a net change of +32 holders.
  • The largest Haemonetics buyer in Q3 2022 was Millennium Management, an estimated $29M added.
  • The largest Haemonetics seller in Q3 2022 was Citadel Advisors, an estimated $45.3M sold.

Based on aggregated 13F filings for Q3 2022.